Irinotecan plus carboplatin versus etoposide plus carboplatin in extensive disease small cell lung cancer: Results of the German randomized phase III trial

被引：0
|
作者：
Schmittel, A. H. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Sebastian, M. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
von Weikersthal, L. Fischer [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Gauler, T. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Hortig, P. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Fischer, J. R. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Link, H. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Binder, D. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Eberhardt, W. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Keilholz, U. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
机构：
[1] Charite, Campus Benjamin Franklin, Berlin, Germany
[2] 3rd Med Clin, Mainz, Germany
[3] MVZ Gesundheitsztr St Marien, Amberg, Germany
[4] W German Canc Ctr, Essen, Germany
[5] Charite Campus Benjamin Franklin, Berlin, Germany
[6] Klinikum Lowenstein, Lowenstein, Germany
[7] Westpfalz Kliniken, Kaiserslautern, Germany
[8] Charite Campus Virchow, Berlin, Germany
[9] W German Canc Ctr, Essen, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8029
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Randomized phase II trial of irinotecan plus cisplatin (IP) versus irinotecan, cisplatin plus etoposide (IPE) every three weeks in patients with extensive disease small cell lung cancer (ED-SCLC).
    Sekine, I.
    Nokihara, H.
    Takeda, K.
    Nishiwaki, Y.
    Nakagawa, K.
    Isobe, H.
    Mori, K.
    Matsui, K.
    Saijo, N.
    Tamura, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 385S - 385S
  • [42] Randomized phase II trial of the biweekly schedule of adjuvant chemotherapy with carboplatin plus paclitaxel versus carboplatin plus gemcitabine in patients with non-small cell lung cancer (NSCLC)
    Sugio, K.
    Nagashima, A.
    Nakanishi, R.
    Uchiyama, A.
    Inoue, M.
    Osaki, T.
    Yoshimatsu, T.
    Takenoyama, M.
    Hanagiri, T.
    Yasumoto, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [43] Carboplatin plus paclitaxel in extensive small cell lung cancer: a multicentre phase 2 study
    Gridelli, C
    Manzione, L
    Perrone, F
    Veltri, E
    Cioffi, R
    Caprio, MG
    Frontini, L
    Rossi, A
    Barletta, E
    Barzelloni, ML
    Bilancia, D
    Gallo, C
    BRITISH JOURNAL OF CANCER, 2001, 84 (01) : 38 - 41
  • [44] A Phase II/III study comparing carboplatin and irinotecan with carboplatin and etoposide for the treatment of elderly patients with extensive-disease small-cell lung cancer (JCOG1201)
    Eba, Junko
    Shimokawa, Tsuneo
    Nakamura, Kenichi
    Shibata, Taro
    Misumi, Yuki
    Okamoto, Hiroaki
    Yamamoto, Noboru
    Ohe, Yuichiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (01) : 115 - 118
  • [45] Carboplatin plus paclitaxel in extensive small cell lung cancer: a multicentre phase 2 study
    C Gridelli
    L Manzione
    F Perrone
    E Veltri
    R Cioffi
    M Grazia Caprio
    L Frontini
    A Rossi
    E Barletta
    M L Barzelloni
    D Bilancia
    C Gallo
    British Journal of Cancer, 2001, 84 : 38 - 41
  • [46] A randomized phase II/III study comparing carboplatin and irinotecan with carboplatin and etoposide for the treatment of elderly patients with extensive-disease small cell lung cancer (JCOG1201/TORG1528).
    Shimokawa, Tsuneo
    Misumi, Yuki
    Okamoto, Hiroaki
    Hosomi, Yukio
    Okamoto, Isamu
    Tanaka, Hiroshi
    Atagi, Shinji
    Hida, Toyoaki
    Goto, Koichi
    Akamatsu, Hiroaki
    Kubota, Kaoru
    Nakagawa, Kazuhiko
    Horinouchi, Hidehito
    Ando, Masahiko
    Machida, Ryunosuke
    Eba, Junko
    Kataoka, Tomoko
    Ohe, Yuichiro
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [47] A Phase I Clinical Trial of Irinotecan and Carboplatin in Patients with Extensive Stage Small Cell Lung Cancer
    Crabb, Simon J.
    Bradbury, Jennifer
    Nolan, Luke
    Selman, Diana
    Muthuramalingam, Sethupathi R.
    Cave, Judith
    Johnson, Peter W. M.
    Ottensmeier, Christian
    CHEMOTHERAPY, 2012, 58 (04) : 257 - 263
  • [48] Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer
    Noda, W
    Nishiwaki, Y
    Kawahara, M
    Negoro, S
    Sugiura, T
    Yokoyama, A
    Fukuoka, M
    Mori, K
    Watanabe, K
    Tamura, T
    Yamamoto, S
    Saijo, N
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (02): : 85 - 91
  • [49] Cisplatin/carboplatin plus etoposide plus vinorelbine in advanced non-small-cell lung cancer: A multicentre randomised trial
    Comella, P
    Frasci, G
    DeCataldis, G
    Panza, N
    Cioffi, R
    Curcio, C
    Belli, M
    Bianco, A
    Ianniello, G
    Maiorino, L
    DellaVittoria, M
    Perchard, J
    Comella, G
    BRITISH JOURNAL OF CANCER, 1996, 74 (11) : 1805 - 1811
  • [50] Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: A Southwest Oncology Group trial
    Kelly, K
    Crowley, J
    Bunn, PA
    Presant, CA
    Grevstad, PK
    Mainpour, CM
    Ramsey, SD
    Wozniak, AJ
    Weiss, GR
    Moore, DF
    Israel, VK
    Livingston, RB
    Gandara, DR
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (13) : 3210 - 3218
12345